Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)
Pharma-Bio Serv posted quarterly Short term Debt of $1.3 million for Q2 2021, up 100.0% year-on-year from $643900.0 in Q2 2020, and little changed on a QoQ basis from $1.3 million in Q1 2021.
Pharma-Bio Serv (PBSV) has 2 years of Short term Debt data on file, last reported at $1.3 million in Q2 2021.
- For the quarter ending Q2 2021, Short term Debt rose 100.0% year-over-year to $1.3 million; the trailing twelve-month figure through Apr 2021 stood at $1.3 million (up 100.0% YoY), and the FY2020 full-year result was $1.3 million, changed N/A from the prior year.
- Short term Debt for Q2 2021 stood at $1.3 million, roughly flat from $1.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $1.3 million in Q4 2020 and bottomed at $643900.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 1.29 Mn |
| Jan 31, 2021 | 1.29 Mn |
| Oct 31, 2020 | 1.29 Mn |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 643,900.00 |